We have previously shown that incubation of human macrophages with antigen-antibody complexes prepared with native human low density lipoprotein (LDL) and rabbit anti-LDL antibodies (LDL-ICs) results in an increased intracellular accumulation of cholesteryl esters (CEs) and induces a marked increase in the number of LDL receptors. To determine whether the increased CE accumulation in these cells occurred during incubation of the cells with LDL-ICs or whether it was secondary to the uptake of LDL by overexpressed LDL receptors, we incubated human macrophages with LDL-ICs for 22 hours, followed by incubation with native LDL for another 20 hours. We found that about 90% of the accumulated CEs could be accounted for by the first incubation with LDL-ICs. We then proceeded to show that the CEs accumulated during incubation of cells with LDL-ICs was secondary to enhanced uptake and impaired degradation of the LDL complexed with immunoglobulin G (IgG) (LDL-IC), which led to a marked intracellular accumulation of undegraded LDL (levels 199-fold higher than those obtained when the cells were incubated with the same concentration of native LDL not complexed with IgG). We have also shown that not all CEs accumulated in these cells were derived from accumulation of undegraded LDL and that some of them were derived from the reesterifkation of free cholesterol released during hydrolysis of LDL. LDL-ICs promoted increased CE accumulation and foam cell formation at concentrations as low as 25 jug/ml. To determine which receptors were involved in the uptake of LDL-ICs, we performed experiments in which the uptake of LDL-ICs was competitively inhibited with heat-aggregated gamma globulin, native LDL, 0-very low density lipoprotein, or acetylated LDL. Our results demonstrated that LDL-IC uptake was most effectively inhibited by heat-aggregated gamma globulin, partially inhibited by native LDL or by a monoclonal antibody to the LDL receptor, and not inhibited by acetylated LDL or 0-very low density lipoprotein. Thus, we conclude that the majority of LDL-ICs are taken up through Fey receptors. Finally, we investigated whether the increase in LDL receptor expression was dependent on the receptor pathway used by the LDL-ICs, and we were able to demonstrate that when macrophages were incubated with LDL-ICs prepared with F(ab') 2 fragments of the anti-LDL antibody, LDL receptor expression was not enhanced. Therefore, we postulate that the uptake of LDL-ICs through Fey receptors results in an uncoupling of the normal regulation of the LDL receptor expression. (Arteriosclerosis and Thrombosis 1991;11:1356-1367)
T he initial stages of atherogenesis are characterized by the subendothelial accumulation of foam cells. 1 Substantial experimental evidence suggests that the majority of foam cells present in atheromatous lesions are derived from monocytes/ derstood. Therefore, there is considerable interest in studying the factors that influence lipoprotein metabolism in macrophages, in the hope that such studies will contribute to an understanding of the genesis and progression of atherosclerosis.
Numerous studies have shown that intracellular accumulation of lipids in monocyte-derived macrophages can occur when chemically or biologically modified LDLs are taken up through the scavenger receptor. 6 -9 Accumulating evidence from our laboratory and others suggests that monocyte-derived macrophages may have additional receptors, distinct from the scavenger receptor, that participate in the recognition and removal of an overlapping range of modified products, 10 including minimally modified lipoproteins such as glucosylated LDL 11 and advanced glycolation end product-modified LDL 12 and that the uptake of these lipoproteins by macrophages may also lead to intracellular accumulation of lipids.
Furthermore, in certain conditions lipoproteins or lipoprotein complexes taken up by the LDL receptor may also lead to foam cell formation. 1314 The notion that LDL taken up by the classical LDL receptor would not be accumulated intracellularly was first challenged by Tabas et al, 15 who showed that the J774 murine macrophage-like tumor cell line had increased uptake of native LDL and concomitant cholesteryl ester (CE) accumulation. 15 In addition, it has been shown that the LDL receptor of human macrophages can bind a variety of ligands other than native LDL, such as )3-very low density lipoprotein, 1316 lipoprotein(a), 17 - 18 and chylomicron remnants, 19 as well as complexes of LDL and lipopolysaccharide 14 and LDL-anti-LDL immune complexes (LDL-ICs). 20 Experimentally, several of these lipoproteins and lipoprotein complexes have been shown to lead to macrophage transformation into foam cells, even though binding and uptake occur (at least partially) through the classical LDL receptor. Furthermore, the metabolism of native LDL may be affected by the state of activation of the macrophages. In previous studies we demonstrated increased uptake of native LDL and subsequent CE accumulation in human macrophages stimulated with microbial or microbial-related products. 21 Recently, we have shown that the stimulation of human macrophages with LDL-ICs leads to a marked increase in native LDL uptake and subsequent intracellular CE accumulation. 20 We have also shown that the increase in native LDL uptake was due to an increase in the expression of LDL receptors. 20 In the present study we have performed experiments to determine the mechanisms leading to the massive CE accumulation observed in macrophages incubated with LDL-ICs, to define the relative contributions for CE accumulation by the uptake of LDL-ICs and of native LDL, and to investigate whether the uptakes of LDL-ICs by the Fey and by the LDL receptor are equally able to stimulate LDL receptor expression and uptake of native LDL.
Methods

Isolation and Characterization of MonocytesI Macrophages
Monocytes were isolated from leukapheresis specimens by countercurrent centrifugal elutriation as previously described. 20 " 23 The leukapheresis specimens used for the separation of monocytes were obtained from normal volunteers by use of a Celltrifuge II apparatus. Donors with abnormalities detected by physical or laboratory examinations were excluded as previously described. 23 The purity of the monocyte preparations obtained by elutriation was confirmed by morphological examination of Wright's-stained cytocentrifuge preparations, by nonspecific esterase staining, and by their ability to ingest latex particles. 24 Viability was determined by Trypan blue dye exclusion. The average purity of the monocytes used in this study, as determined by Wright's staining, was 93%; by esterase staining, 92%; and by latex ingestion, 93%. The average viability of the cells employed was 99%.
The isolated monocytes were matured by incubation at 37°C for 8 days in a humidified incubator with a 5% CO 2 atmosphere. The medium used to induce maturation was a defined supplemented Iscove's modified Dulbecco's medium prepared as previously described 21 - 25 and containing 30% (vol/vol) of whole human serum (Whittaker M.A. Bioproducts, Walkersville, Md.). The protein content of the macrophages was, on average, three times higher than that of monocytes; thus, the pooled human serum used was not toxic to the cells. After maturation of monocytes into macrophages, medium without addition of whole human serum and without cholesterol supplementation was used to perform all the experiments.
Lipoprotein Isolation, Modification, and Labeling
Blood was collected in EDTA (1 mg/ml) after 12 hours of fasting. LDLs (1.019<d< 1.063 g/ml) were isolated from plasma by sequential ultracentrifugation on an ultracentrifuge (Beckman L5-50, type 50 rotor 26 ), washed by ultracentrifugation, dialyzed against a 0.15 M NaCl solution containing 1 mM EDTA (pH 7.4), and stored under N 2 in the dark. They were passed through an Acrodisc filter (0.2 -^m pore size) to remove aggregates. An aliquot of LDL was iodinated with iodine-125 by the McFarlane procedure as modified by Bratzler et al. 27 The labeling conditions were adjusted to obtain a specific activity of 100-400 cprn/ng protein. Radioactivity localized in the lipid moiety of the lipoproteins was determined after a "Folch lipid extraction" 28 and constituted less than 4% of the total radioactivity. Acetylation of LDL was performed by use of the protocol described by Basu et al. 29 
Preparation of Immune Complexes
Insoluble ICs were prepared with LDL (1 mg/ml) and the immunoglobulin G (IgG) fraction of a rabbit anti-LDL antiserum raised by us 20 at a concentration of 1 mg/ml. A precipitin curve was prepared by incubating 1-mg aliquots of IgG anti-LDL overnight at 4°C with varying amounts of LDL, ranging from 5 to 1,000 fi\. The antigen to antibody ratio yielding the highest amount of precipitate was considered to correspond to the equivalence point and was used for preparation of insoluble ICs. For our particular anti-LDL antibody, equivalence was reached usually at a 1:10 (wt/wt) antigen to antibody ratio. For instance, to prepare 2.5 mg ICs we typically started with 8 mg IgG and 800 fig LDL in eight separate sterile tubes. We then centrifuged (500g, 5 minutes, 4°C) and pooled the precipitates formed, washed the pellet twice with cold sterile phosphate-buffered saline (PBS), and resuspended it in 2-2.5 ml sterile PBS to obtain a final concentration of 1-1.5 mg IC/ml. The protein content of the IC was determined after washing by use of the Bio-Rad protein assay, calibrated with serial dilutions of a preparation of heavily heat-aggregated IgG with known amounts of IgG. Before addition to cell cultures, the IC preparations were sterilized by gamma irradiation. 2 Fragments F(ab') 2 fragments were prepared by a procedure that was modified from Stewart and Stanworth. 30 In brief, rabbit IgG (10-20 mg/ml) was dialyzed for 24 hours at 4°C against two changes of 0.1 M sodium acetate buffer, pH 4.5. The IgG concentration was adjusted to 2 mg/ml with 0.1 M sodium acetate buffer, pH 4.5. Pepsin (Sigma Chemical Company, St. Louis, Mo.) digestion was performed at an enzyme to substrate ratio of 1:100 for 4 hours at 37°C. Digestion was terminated by the addition of solid tris(hydroxymethyl)methylamine to raise the pH to 8.0. NaHSO 4 (Sigma) was then added to the digest at room temperature under constant-stirring conditions until a concentration of 18% of the saturation level was reached. The digest was then centrifuged at 10,000g for 20 minutes. The supernatant was discarded and the precipitate dissolved in distilled water, followed by dialysis for 24 hours at 4°C against two changes of 0.1 M sodium acetate buffer, pH 7.4. Undigested IgG was removed by affinity chromatography in a Protein A-sepharose column as described by Stingl et al. 31 The final preparation was reacted with anti-whole IgG and anti-light chain antisera and failed to react with anti-Fc-y antiserum in doublediffusion studies. The F(ab') 2 fragments retained the ability to form insoluble ICs when mixed with LDL in adequate proportions, as established by means of a precipitin curve run previously to the preparation of ICs to be used in our experiments.
Preparation of F(ab')
Preparation of Heat-Aggregated Gamma Globulin
Human gamma globulin (Sigma) at 20 mg/ml in PBS was heated at 63°C for 20 minutes. Protein content was determined by Bio-Rad assay, and sterility was ensured by gamma irradiation.
CRL-1703 Hybridomas
CRL-1703, a murine hybridoma developed by Huettinger et al 32 33 The CRL-1703 cells were seeded at a density of 2xlO 5 cells/ml in RPMI-1640 supplemented with 10% fetal bovine serum and 4.5% glucose, as recommended. The hybridoma cultures were grown to approximately lxlO 6 cells/ml, after which time the culture supernatants were harvested.
Measurement of Total, Free, and Esterified Cholesterol Content in Macrophages
To perform cholesterol mass studies, the macrophage monolayers after being extensively washed with PBS were extracted with hexane/isopropanol (3:2, vol/vol) as previously described. 34 Free and total cholesterol contents were assayed on a gas chromatograph equipped with an H 2 flame ionization detector. A glass column packed with 3% SP-2250 on 80/100 mesh Supelcoport (Supelco, Bellefonte, Pa.) was used for the chromatographic separation, and its temperature was maintained at 250°C during the separation. N 2 was used as the gas carrier. For assay of total cholesterol the cellular extracts were evaporated to dryness, and the residue was hydrolyzed by Ishikawa's method 35 as previously described. 26 CE levels were obtained by subtracting free cholesterol from total cholesterol levels. j6-Stigmasterol was used as an internal standard.
Cholesteryl Ester Synthesis
CE synthesis was measured in the presence or absence of 50 fiM chloroquine as previously described by us. LDL intracellular accumulation and proteolytic degradation were assessed as previously described. 26 After incubation of the 125 I-labeled LDL or 125 I-LDL-IC with the cells, the medium was removed and the cells washed two times with 1 ml PBS containing 0.2% (wt/vol) bovine serum albumin followed by two additional washes with PBS without albumin. The cells were dissolved in 1 M NaOH, and an aliquot of the solubilized cells was taken to determine the amount of 125 I-LDL radioactivity present in the cell pellet. Another aliquot was used to determine the amount of cellular protein by the Lowry method. 36 The medium was used to determine the proteolytic degradation of LDL, as described by Bierman et al. 37 Intracellular degradation levels were corrected by subtracting the small amounts of 125 I-labeled acidsoluble material obtained due to spontaneous breakdown of LDL when labeled LDL was incubated without cells.
To assay LDL-IC binding, the incubation as well as the washing and harvesting procedures were performed at 4°C instead of 37°C. The incubation period was 3-4 hours. The data that represent specific binding, uptake, and degradation were determined from the difference of the levels measured in the presence and absence of a 25-fold excess of unlabeled ligand.
125
I-labeled LDL-IC isotherm saturation binding studies were performed with increasing concentrations of LDL-IC. Curves representing the best fit were determined by unweighted least-squares nonlinear regression analysis. Scatchard analysis was performed on the saturation binding data as previously described.
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Competition and Blocking Studies
In one series of experiments 125 I-LDL-labeled ICs (50 Mg/ml) were incubated at 4°C for 3-4 hours in the presence of medium alone or in medium containing increasing concentrations of heat-aggregated gamma globulin, native LDL, /3-very low density lipoprotein, or acetylated LDL. After incubation, the cultures were washed and the cellular binding of 125 I-LDL-labeled ICs was determined. In another set of experiments the macrophages were incubated with medium alone or medium containing either native LDL (100 Mg/ml), heat-aggregated gamma globulin (10 mg/ml), or undiluted CRL-1703 hybridoma supernatant for 1 hour at 37°C. After that period unlabeled LDL-ICs (250 Mg/ml) were added to each well and the cells incubated for another 22 hours. The cells were washed, and their lipid content was extracted, as previously described, for measurement of total, free, and esterified cholesterol by gas chromatography.
To perform the blocking experiments, macrophages were incubated for 22 hours at 37°C with medium alone or medium containing LDL-ICs (250 Mg/ml), F(ab') 2 -ICs (250 Mg/ml), LDL-IC (250 fig/ ml) plus heat-aggregated gamma globulin (10 mg/ ml), or LDL-ICs (250 Mg/ml) plus LDL (250 Mg/ml). After incubation the medium was removed, the cells were extensively washed, and 125 I-LDL (10 Mg/ml) was added to the macrophages with or without the addition of a 25-fold excess of unlabeled LDL. The cells were then incubated for 20 hours at 37°C and after this period, they were washed and the cellular binding of 125 I-LDL was determined.
Statistics
Statistical analysis was performed with the mean paired Student's t test and the Wilcoxon signed rank test to compare the differences between paired data. For evaluation of differences between means in unpaired data, the Wilcoxon rank sum test and Student's t test were used. Results are reported as mean±SEM. Significance was assumed for probability values less than 0.05.
Results
In a previous report, 20 we presented data showing that human macrophages after being stimulated for 22 hours with LDL-ICs accumulated approximately six times the amount of native LDL and expressed approximately 20-fold more LDL receptors than did unstimulated macrophages. This increased uptake of native LDL was associated with increased intracellular accumulation of cholesterol and CEs and morphological transformation of macrophages into "foam cells." To determine whether the intracellular accumulation of CEs in LDL-IC-stimulated cells was mainly due to the enhanced uptake of native LDL or to the intracellular accumulation of the LDL taken up by the cell as an IC, we compared the levels of total cholesterol and CEs in macrophages stimulated with LDL-ICs with or without subsequent exposure to native LDL ( Figure 1 ). There was a marked increase in the total cholesterol and CE content of the LDL-IC-stimulated cells when compared with unstimulated cells, independent of their subsequent exposure to native LDL. There was no significant difference in total cholesterol and CE mass in unstimulated human macrophages incubated in the presence or absence of native LDL (data not shown). In contrast, a small but statistically significant difference (p<0.05) was found both in total cholesterol and CE mass in LDL-IC-stimulated macrophages exposed to native LDL versus those that were incubated with LDL-ICs alone. However, 90-92% of the CE content of macrophages stimulated with LDLICs and incubated after stimulation with native LDL was secondary to the uptake of the LDL contained in LDL-ICs. The subsequent uptake of native LDL contributed only 8-10% to the cellular CE mass.
Because the majority of CE accumulated was due to LDL-IC uptake, we decided to investigate whether LDL complexed with IgG (LDL-IC) was taken up by the macrophages to a greater extent than native LDL. Thus, we incubated human macrophages with the same concentration of I-LDL-ICs, we could not accurately determine the rate of degradation of the LDL taken up as part of an LDL-IC at the start of the experiment as a function of time in culture. Thus, we performed a pulse-chase experiment by initially incubating human macrophages for 2 hours at 4°C with To determine whether the CE accumulation in LDL-IC-stimulated cells was entirely due to accumulation of the intact LDL contained in the IC, we measured acyl coenzyme A: cholesterol acyltransferase (ACAT) activity in these cells in the presence or absence of chloroquine, an inhibitor of lysosomal degradation. The concentration of chloroquine was determined in dose-response cellular viability studies, and a concentration of 50 /nM was shown to inhibit 125 I-LDL-IC degradation by more than 80%, while cellular viability remained satisfactory (>90%). As shown in Figure 4 , CE synthesis was determined in two sets of human macrophages: one set served as the unstimulated experimental control (A), while the other set was incubated with LDL-ICs (250 fig/m\) (B). Each set was treated similarly with or without 50 fiM chloroquine. In the unstimulated macrophages, carbon-14-labeled oleate incorporation into CE did not differ significantly in cultures containing or lacking chloroquine. However, in macrophages stimulated with LDL-ICs, [ To determine whether LDL-ICs were taken up by macrophages through a receptor-mediated pathway or through a nonspecific mechanism, saturation binding isotherm studies were performed with progressively increasing concentrations of 125 I-LDL-labeled ICs with or without a 25-fold excess of unlabeled LDL-IC to determine nonspecific binding. These studies ( Figure 5 The next point that we investigated was whether LDL-ICs were taken up by the macrophages as a consequence of binding to Fey, LDL, LDL-related, or scavenger receptors. This point was addressed by competition studies in which the LDL-IC was used as the radioligand and heat-aggregated gamma globulin, native LDL, j8-very low density lipoprotein, and acetylated LDL were used as competing ligands. Figure 6 illustrates that acetylated LDL did not inhibit 125 I-LDL-IC binding, whereas both native LDL and heat-aggregated gamma globulin inhibited binding of 125 I-LDL-IC in a concentration-dependent fashion up to a maximum of approximately 25% for FIGURE 
. Bar graph showing cholesteryl ester synthesis by monocyte-derived macrophages. "A " represents unstimulated macrophages in the absence (C) or presence (C+CLQ) of 50 \M chloroquine; "B" represents low density lipoprotein-immune complex-stimulated macrophages in the absence (IC) or presence (IC+CLQ) of 50 fiM chloroquine. After a 22-hour stimulation at 37"C, cells
Line plot of effect of unlabeled lipoproteins and heat-aggregated gamma globulin (HAGG) to compete for binding of 50 fig/ml iodine-125-labeled low density lipoprotein-immune complexes (LDL-ICs), which contained approximately 3 fig labeled LDL (specific activity, 400 cpm/ng). Human macrophages were incubated at 4°C in 1 ml medium containing 50 fig l25 I-LDL-ICs and indicated concentrations of acetylated LDL (•), native LDL (A) (scale "A" in micrograms per milliliter), or HAGG (•) (scale "B" in milligrams per milliliter). After incubation for 4 hours, cells were harvested and the amount of m I-LDL-ICs bound to cells was determined. Results are expressed as percentages of binding of 50 fig/ml m I-LDL-ICs in the absence of competitor. 100% equals 15.4 ug I25 I-LDL-IC bound/mg cell protein/4 hr.
native LDL and 70% for heat-aggregated gamma globulin. The binding of 50 /xg/ml LDL-IC in the presence of increasing concentrations of /J-very low density lipoprotein (50,100, 175, and 250 fig/mY) was 89%, 107%, 105%, and 105%, respectively, of the levels obtained when )3-very low density lipoprotein was absent. Similar studies with a monoclonal antibody against the LDL receptor (CRL-1703) as well as a monoclonal antibody against rat liver glutathione-5-transferase B, subunit YaYc (a gift from Irene Y. Wang, Department of Biochemistry, Medical University of South Carolina) were also performed. The latter monoclonal antibody was chosen as a negative control because it should not affect either LDL or IC uptake. The cells were incubated for 1 hour at 4°C with either medium containing 15% fetal calf serum, 375 Mg/ml native LDL, and 2.5 mg/ml heat-aggregated IgG, or with the supernatants of either the CRL-1703 murine hybridoma (anti-LDL receptor antibody) or of the hybridoma secreting the monoclonal antibody against the subunit YaYc of rat liver glutathione-5-transferase B. The supernatants of both hybridomas were centrifuged immediately before use at 48,000g for 30 minutes to remove any IgG aggregates that might possibly block the Fey receptor. I-LDL-ICs bound to the cells in the presence of the monoclonal antibody against the LDL receptor, the monoclonal antibody against rat liver glutathione-5-transferase B, heataggregated gamma globulin, and native LDL were, respectively, 72.2±8.7%, 102.9±9.8%, 36.3±2.5%, and 73.8±0.4% of the levels of the LDL-ICs bound to the cells in the presence of medium alone. Therefore, it can be concluded that LDL-ICs bind predominantly to Fey receptors and to a small extent to LDL receptors.
Further experiments were performed to confirm that the uptake of LDL-ICs by macrophages was I-LDL to prepare both compounds, we found that the specific activity of the two types of IC was, respectively, 79 cpm/ng IC for LDL-IgG-IC and 81.6 cpm/ng IC for the LDL-F(ab') 2 -IC. In conclusion, all our experiments are in agreement with the interpretation that the LDL complexed with IgG (LDL-IC) was the main source of intracellular CE and that the uptake of LDL-ICs was mainly mediated by Fey receptors, although a minor portion of LDL-ICs were internalized after binding to the LDL receptor.
We had previously demonstrated 20 that human macrophages stimulated with LDL-ICs have an increased expression of LDL receptors compared with unstimulated cells. Considering that LDL-ICs can interact with macrophages both through Fey receptors and through the LDL receptor, the question arose as to which one of those interactions determined the increased expression of LDL receptor expression. This was investigated by performing twostep experiments, in which we first inhibited LDL-IC uptake with either native LDL or heat-aggregated gamma globulin and then determined the receptormediated accumulation of fied and esterified cholesterol, we performed experiments by incubating human monocyte-derived macrophages with 250 /Ag/ml LDL-IC for 3 and 6 days. At the end of the incubation period, the cells were washed to remove unbound LDL-ICs and then incubated for 20 hours with 10 /Ltg/ml 125 I-labeled LDL in the presence or absence of a 25-fold excess of unlabeled LDL. The However, intracellular CE accumulation can also be due to an increased uptake of native LDL, particularly when the macrophages have been previously activated 21 or when macrophages are incubated with native LDL complexed with IgG (LDL-IC), as we 20 and others 40 have recently reported. We also demonstrated that CE accumulation was associated with a 20-fold increase in LDL receptor number. Neither the accumulation of CE nor the overexpression of LDL receptors was simply due to activation of macrophages by ICs because insoluble ICs prepared with a variety of nonlipoprotein antigens, including keyhole limpet hemocyanin (which has a molecular weight similar to LDL), human IgG, human transferrin, and killed Candida albkans as well as antigenic extracts of C. albicans did not induce the transformation of these cells into foam cells and did not lead to enhanced uptake of native LDL. 20 At least two mechanisms, not mutually exclusive, could contribute to the increased intracellular CE accumulation observed in LDL-IC-stimulated macrophages. One would involve increased CE accumulation secondary to the enhancement in LDL receptor expression and increased uptake of native LDL in the stimulated cells. The other would involve the intracellular accumulation of LDL complexed with IgG during the stimulation of the cells with LDL-IC, due to an impaired degradation of the LDL contained in the IC.
In studies in which we compared the intracellular accumulation of CE in unstimulated macrophages and in macrophages stimulated with LDL-IC before and after their subsequent incubation with native LDL, we observed a marked difference in total and esterified cholesterol content between unstimulated and LDL-IC-stimulated cells even when native LDL was not added to the cultures after stimulation with LDL-ICs. When native LDL was added to the cultures, a further increase in total cholesterol and CE content was observed but only in the LDL-IC-stimulated cells. The contribution of native LDL uptake to the intracellular accumulation of cholesterol in the LDL-IC-stimulated cells was estimated to be between 8-10%.
The major source of intracellular CE appears to be the LDL taken up as part of LDL-IC, as there is a 7.3-fold increase in LDL uptake (accumulation and degradation) when LDL is presented to the macrophage complexed with IgG relative to when it is presented as native LDL. In addition, the degradation of LDL complexed with IgG is impaired, being only 1.09-fold higher than that of native LDL, which leads to a 199-fold increase in the amount of LDL accumulated intracellularly. Comparing the degradation of LDL complexed with IgG with the degradation of native LDL at different time points, we found that the native LDL was virtually taken up and degraded in about 5 hours while the LDL of the LDL-IC, although efficiently taken up in the same period of time, was only partially degraded. Pulsechase experiments have shown that in the first 5 hours, 34% of the LDL complexed with IgG was degraded and that at 48 hours, virtually all LDL (96%) had been degraded. Thus, the accumulation of CE in macrophages incubated with LDL-ICs was primarily due to increased uptake and impaired degradation of the LDL contained in the IC.
The enhanced uptake of LDL complexed with IgG by macrophages could be likely explained by the uptake of the IC by Fey receptors, which may be more efficient than uptake by the LDL receptor, by allowing the ingestion of large complexes with several aggregated LDL molecules. Also, it is possible that uptake by the Fey receptors may also explain the delay in the degradation of LDL, as the increased uptake of large LDL-antibody aggregates may lead to an overload in the lysosomal compartment of the cell. The major participation of Fc-y receptors in the recognition of LDL-ICs was confirmed by competition studies, which showed that the greatest degree of inhibition (75%) of LDL-IC binding was obtained with heat-aggregated gamma globulin, whereas LDL only inhibited LDL-IC binding by 25%. Competition with acetylated LDL or /3-very low density lipoprotein did not inhibit the binding of LDL-IC, ruling out the participation of the scavenger and LDL-related receptors in the uptake of LDL-ICs. The same conclusions were reached when a monoclonal antibody against LDL receptor was found to block 125 I-LDL-IC binding in a similar manner. The specificity of the block was confirmed when an irrelevant monoclonal antibody secreted into a medium with similar composition failed to inhibit the uptake of 125 I-LDL-IC by the cells. Furthermore, similar conclusions were reached when the effects of preincubation with heat-aggregated gamma globulin, native LDL, or acetylated LDL on CE accumulation were studied. In addition, LDL-ICs prepared with the F(ab') 2 fragment of anti-LDL antibody induced CE accumulation to levels approximately 28% of those seen with complete LDL-ICs. Thus, we can safely conclude that LDL-IC uptake occurs through two receptor pathways-primarily through Fc-y receptors and to a lesser degree through the LDL receptor pathway.
It is interesting to note that phagocytosis of LDL aggregates, which seems to involve the classical LDL receptor, is also followed by CE accumulation and foam cell formation. 41 These observations suggest that the interaction with LDL receptors can be associated with pynocytosis (native LDL) or phagocytosis (aggregated LDL and perhaps some LDL-IC). Therefore, a general rule seems to emerge: while pynocytotic internalization is associated with the well-known tight regulation of intracellular cholesterol levels and expression of LDL receptor, phagocytosis is not. Whether this is a reflection of the incorporation into different intracellular pools or of some other mechanism can only be a matter of speculation at this time.
A most paradoxical finding in our experiments is the increased expression of LDL receptors in cells that have a markedly increased level of intracellular cholesterol. This increased expression is maintained for an extended period of time (up to 6 days) regardless of the level of intracellular cholesterol. We considered the possibility that this could be secondary to cell activation and subsequent to the ingestion of LDL-ICs via Fey receptors. If so, we should have been able to abrogate the increase when the Fey receptors were blocked. Indeed, when the Fey receptors were blocked with heat-aggregated gamma globulin, the accumulation of 125 I-LDL added subsequently to incubation of the macrophages with LDL-ICs was significantly reduced (84%), but a marked reduction (58%) was also seen when the LDL receptor was blocked with native LDL before addition of the LDL-IC. These results seem to suggest that LDL-IC, taken up via either the LDL receptor or the Fey receptor, had the capability of stimulating LDL receptor expression. However, because the addition of native LDL to block LDL receptors may not only block the receptors but also downregulate their expression, the subsequent incubation of these cells with LDL-ICs was likely to have a less marked effect on the expression of LDL receptors, explaining at least in part the 58% decrease in LDL uptake observed. To circumvent this difficulty, we performed experiments with LDL-F(ab') 2 -IC, which will not bind to Fey receptors but will bind to the LDL receptor, and demonstrated that the upregulation of the LDL receptor could not be induced with LDL-F(ab') 2 -IC. Therefore, it appears as if the interaction of the LDL-IC with Fey receptors is responsible for the subsequent increase in the expression of LDL receptors in LDL-IC-stimulated cells. The cellular mechanisms responsible for this increased expression of LDL receptors have yet to be defined.
It is possible that LDL bound to anti-LDL antibody and taken up through Fey receptors is incorporated into a cellular cholesterol pool that differs significantly from that used by LDL taken up through the LDL receptor. This could lead to an increased availability of free cholesterol to ACAT and to a decrease in the regulatory free cholesterol pool, with subsequent increase in LDL receptor expression. Alternatively, macrophage activation may result in cholesterol translocation from the plasma membrane pool to the ACAT substrate pool, depleting membrane cholesterol pools and in effect increasing the cellular requirement for membrane cholesterol. Against this hypothesis is the lack of an increase in LDL receptor expression in cells stimulated by ICs containing antigens other than lipoproteins.
The clinical significance of our findings hinges heavily on the natural occurrence of anti-LDL antibodies and the formation of LDL-ICs in vivo. Anti-LDL antibodies have been described in patients with arteriosclerosis, 42 " 44 and LDL isolated from patients with coronary heart disease has been shown to be immunologically different from native LDL. It is also known that the respiratory burst of macrophages is associated with the release of reactive oxygen intermediates and other products 45 - 46 that have the potential of modifying LDL. 47 - 49 Such modifications, interestingly enough, are associated with increased immunogenicity and production of anti-LDL antibodies.
50
- 52 Witztum and coworkers 52 demonstrated that the antibodies to modified lipoproteins were directed against the added radicals and failed to react with native LDL. However, most tests developed for the detection of anti-LDL antibodies in humans have used unmodified LDL as antigen, therefore suggesting that a diversity of antibodies may be formed with different specificities and cross-reactivities. In any case, these anti-LDL antibodies have the potential to react with LDL and form LDL-ICs. In the studies reported in this article, we used insoluble LDLICs as models. Insoluble ICs are not likely to exist in the circulation for extended periods of time but could very well be formed in an already altered arterial cell wail when LDL has diffused into the subendothelial space, where it will be likely to react with anti-LDL antibodies. Furthermore, experiments performed in our laboratory have demonstrated that erythrocyte-bound ICs are even more efficient than insoluble ICs in inducing the intracellular CE accumulation and foam-cell formation. 53 Thus, although it is tempting to postulate that the LDL-ICs may play a role in the pathogenesis of atherosclerosis, it is rather premature to speculate about their clinical relevance. The investigation of a possible connection between the development of arteriosclerosis and the presence of LDL-ICs in an animal model would help to answer this interesting question.
